32000863|t|Wwox deficiency leads to neurodevelopmental and degenerative neuropathies and glycogen synthase kinase 3beta-mediated epileptic seizure activity in mice.
32000863|a|Human WWOX gene resides in the chromosomal common fragile site FRA16D and encodes a tumor suppressor WW domain-containing oxidoreductase. Loss-of-function mutations in both alleles of WWOX gene lead to autosomal recessive abnormalities in pediatric patients from consanguineous families, including microcephaly, cerebellar ataxia with epilepsy, mental retardation, retinal degeneration, developmental delay and early death. Here, we report that targeted disruption of Wwox gene in mice causes neurodevelopmental disorders, encompassing abnormal neuronal differentiation and migration in the brain. Cerebral malformations, such as microcephaly and incomplete separation of the hemispheres by a partial interhemispheric fissure, neuronal disorganization and heterotopia, and defective cerebellar midline fusion are observed in Wwox-/- mice. Degenerative alterations including severe hypomyelination in the central nervous system, optic nerve atrophy, Purkinje cell loss and granular cell apoptosis in the cerebellum, and peripheral nerve demyelination due to Schwann cell apoptosis correspond to reduced amplitudes and a latency prolongation of transcranial motor evoked potentials, motor deficits and gait ataxia in Wwox-/- mice. Wwox gene ablation leads to the occurrence of spontaneous epilepsy and increased susceptibility to pilocarpine- and pentylenetetrazol (PTZ)-induced seizures in preweaning mice. We determined that a significantly increased activation of glycogen synthase kinase 3beta (GSK3beta) occurs in Wwox-/- mouse cerebral cortex, hippocampus and cerebellum. Inhibition of GSK3beta by lithium ion significantly abolishes the onset of PTZ-induced seizure in Wwox-/- mice. Together, our findings reveal that the neurodevelopmental and neurodegenerative deficits in Wwox knockout mice strikingly recapitulate the key features of human neuropathies, and that targeting GSK3beta with lithium ion ameliorates epilepsy.
32000863	25	73	neurodevelopmental and degenerative neuropathies	Disease	MESH:D019636
32000863	78	108	glycogen synthase kinase 3beta	Gene	56637
32000863	118	135	epileptic seizure	Disease	MESH:D004827
32000863	148	152	mice	Species	10090
32000863	154	159	Human	Species	9606
32000863	160	164	WWOX	Gene	51741
32000863	238	254	tumor suppressor	Disease	OMIM:601308
32000863	255	290	WW domain-containing oxidoreductase	Gene	51741
32000863	338	342	WWOX	Gene	51741
32000863	356	389	autosomal recessive abnormalities	Disease	MESH:D002869
32000863	403	411	patients	Species	9606
32000863	452	464	microcephaly	Disease	MESH:D008831
32000863	466	483	cerebellar ataxia	Disease	MESH:D002524
32000863	489	497	epilepsy	Disease	MESH:D004827
32000863	499	517	mental retardation	Disease	MESH:D008607
32000863	519	539	retinal degeneration	Disease	MESH:D012162
32000863	541	560	developmental delay	Disease	MESH:D002658
32000863	565	576	early death	Disease	MESH:D003643
32000863	622	626	Wwox	Gene	80707
32000863	635	639	mice	Species	10090
32000863	647	675	neurodevelopmental disorders	Disease	MESH:D002658
32000863	752	774	Cerebral malformations	Disease	MESH:D020786
32000863	784	796	microcephaly	Disease	MESH:D008831
32000863	910	921	heterotopia	Disease	MESH:D054091
32000863	979	983	Wwox	Gene	80707
32000863	987	991	mice	Species	10090
32000863	1035	1050	hypomyelination	Disease	MESH:D003711
32000863	1082	1101	optic nerve atrophy	Disease	MESH:D009896
32000863	1173	1203	peripheral nerve demyelination	Disease	MESH:D011129
32000863	1335	1349	motor deficits	Disease	MESH:D009461
32000863	1354	1365	gait ataxia	Disease	MESH:D020234
32000863	1369	1373	Wwox	Gene	80707
32000863	1377	1381	mice	Species	10090
32000863	1383	1387	Wwox	Gene	80707
32000863	1441	1449	epilepsy	Disease	MESH:D004827
32000863	1482	1493	pilocarpine	Chemical	MESH:D010862
32000863	1499	1516	pentylenetetrazol	Chemical	MESH:D010433
32000863	1518	1521	PTZ	Chemical	MESH:D010433
32000863	1531	1539	seizures	Disease	MESH:D012640
32000863	1554	1558	mice	Species	10090
32000863	1619	1649	glycogen synthase kinase 3beta	Gene	56637
32000863	1651	1659	GSK3beta	Gene	56637
32000863	1671	1675	Wwox	Gene	80707
32000863	1679	1684	mouse	Species	10090
32000863	1744	1752	GSK3beta	Gene	56637
32000863	1756	1767	lithium ion	Chemical	-
32000863	1805	1808	PTZ	Chemical	MESH:D010433
32000863	1817	1824	seizure	Disease	MESH:D012640
32000863	1828	1832	Wwox	Gene	80707
32000863	1836	1840	mice	Species	10090
32000863	1881	1930	neurodevelopmental and neurodegenerative deficits	Disease	MESH:D019636
32000863	1934	1938	Wwox	Gene	80707
32000863	1948	1952	mice	Species	10090
32000863	1997	2002	human	Species	9606
32000863	2003	2015	neuropathies	Disease	MESH:D009422
32000863	2036	2044	GSK3beta	Gene	56637
32000863	2050	2061	lithium ion	Chemical	-
32000863	2074	2082	epilepsy	Disease	MESH:D004827
32000863	Association	MESH:D008831	51741
32000863	Association	MESH:D003643	51741
32000863	Association	MESH:D004827	80707
32000863	Association	MESH:D009422	80707
32000863	Association	MESH:D010433	80707
32000863	Association	MESH:D012640	80707
32000863	Association	MESH:D004827	51741
32000863	Association	MESH:D020786	80707
32000863	Association	MESH:D004827	56637
32000863	Positive_Correlation	MESH:D010862	MESH:D012640
32000863	Association	MESH:D011129	80707
32000863	Association	MESH:D002658	80707
32000863	Association	MESH:D003711	80707
32000863	Association	MESH:D019636	80707
32000863	Association	MESH:D008831	80707
32000863	Negative_Correlation	MESH:D010862	80707
32000863	Positive_Correlation	MESH:D010433	MESH:D012640
32000863	Association	56637	80707
32000863	Association	MESH:D012162	51741
32000863	Positive_Correlation	MESH:D010862	MESH:D004827
32000863	Association	MESH:D054091	80707
32000863	Association	MESH:D009896	80707
32000863	Association	MESH:D002524	51741
32000863	Association	MESH:D002658	51741
32000863	Association	OMIM:601308	51741
32000863	Association	MESH:D008607	51741

